tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Pfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema
PremiumCompany AnnouncementsPfizer’s New Study on Abrocitinib: A Potential Breakthrough for Pediatric Eczema
9h ago
Pfizer’s Ngenla Study: A Closer Look at Long-Term Safety for GHD Treatment
Premium
Company Announcements
Pfizer’s Ngenla Study: A Closer Look at Long-Term Safety for GHD Treatment
9h ago
Pfizer’s Abrysvo Study: A Closer Look at Safety in Pregnant Women and Infants
Premium
Company Announcements
Pfizer’s Abrysvo Study: A Closer Look at Safety in Pregnant Women and Infants
9h ago
Is MRNA Stock (MRNA) a Buy Ahead of Q2 Earnings?
PremiumMarket NewsIs MRNA Stock (MRNA) a Buy Ahead of Q2 Earnings?
1d ago
Trump posts letters calling on drug company CEOs to lower prices
Premium
The Fly
Trump posts letters calling on drug company CEOs to lower prices
1d ago
Press Secretary says Trump sent letters today to pharmaceutical companies
Premium
The Fly
Press Secretary says Trump sent letters today to pharmaceutical companies
1d ago
Pfizer’s COVID-19 Vaccine Study: Key Insights and Market Impact
PremiumCompany AnnouncementsPfizer’s COVID-19 Vaccine Study: Key Insights and Market Impact
1d ago
Pfizer’s Elranatamab Study: Continued Access for Multiple Myeloma Patients
Premium
Company Announcements
Pfizer’s Elranatamab Study: Continued Access for Multiple Myeloma Patients
1d ago
Pfizer and Bristol-Myers Squibb’s Promising Study on Multiple Myeloma Treatment
Premium
Company Announcements
Pfizer and Bristol-Myers Squibb’s Promising Study on Multiple Myeloma Treatment
1d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100